[(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDRO-2-FURANYL]METHYL SULFAMATE RNA linking ATOMN C10 H14 N6 O6 S 0 2002-09-11 2011-06-04 N REL 346.320 N LMS N Corina V3.40 N EBI N9 N 0 1 Y N N 34.326 43.711 75.183 1.690 -0.166 0.095 N9 LMS 1 C8 C 0 1 Y N N 34.444 44.958 75.754 1.476 -1.398 -0.447 C8 LMS 2 N7 N 0 1 Y N N 34.326 44.953 77.063 2.609 -2.021 -0.598 N7 LMS 3 C5 C 0 1 Y N N 34.125 43.616 77.376 3.619 -1.230 -0.163 C5 LMS 4 C6 C 0 1 Y N N 33.907 42.946 78.601 5.015 -1.366 -0.083 C6 LMS 5 N6 N 0 1 N N N 33.835 43.556 79.788 5.640 -2.524 -0.510 N6 LMS 6 N1 N 0 1 Y N N 33.752 41.608 78.562 5.722 -0.356 0.414 N1 LMS 7 C2 C 0 1 Y N N 33.795 40.991 77.374 5.134 0.753 0.824 C2 LMS 8 N3 N 0 1 Y N N 33.977 41.506 76.160 3.830 0.925 0.768 N3 LMS 9 C4 C 0 1 Y N N 34.138 42.838 76.230 3.042 -0.030 0.286 C4 LMS 10 N N 0 1 N Y N 34.746 48.120 70.025 -4.233 -2.142 -0.948 N LMS 11 S S 0 1 N N N 35.161 48.006 71.607 -4.725 -0.988 0.133 S LMS 12 HA H 0 1 N N N 33.523 42.522 70.101 -0.624 4.258 -0.465 HA LMS 13 HB H 0 1 N N N 31.916 43.017 74.067 1.194 3.526 -1.470 HB LMS 14 H8 H 0 1 N N N 34.617 45.856 75.180 0.509 -1.799 -0.712 H8 LMS 15 H2 H 0 1 N N N 33.663 39.920 77.406 5.747 1.550 1.222 H2 LMS 16 O1P O 0 1 N N N 36.592 48.315 71.791 -5.422 -0.004 -0.620 O1P LMS 17 O2P O 0 1 N N N 34.161 48.717 72.436 -5.306 -1.685 1.227 O2P LMS 18 O5* O 0 1 N N N 34.973 46.471 71.984 -3.473 -0.311 0.671 O5' LMS 19 C5* C 0 1 N N N 35.786 45.455 71.376 -2.861 0.595 -0.249 C5' LMS 20 C4* C 0 1 N N R 35.278 44.080 71.751 -1.618 1.214 0.394 C4' LMS 21 O4* O 0 1 N N N 35.531 43.836 73.168 -0.619 0.201 0.598 O4' LMS 22 C3* C 0 1 N N S 33.781 43.829 71.536 -1.013 2.272 -0.548 C3' LMS 23 O3* O 0 1 N N N 33.570 42.507 71.050 -0.996 3.554 0.084 O3' LMS 24 C2* C 0 1 N N R 33.217 43.941 72.950 0.431 1.774 -0.800 C2' LMS 25 O2* O 0 1 N N N 32.038 43.186 73.140 1.357 2.862 -0.786 O2' LMS 26 C1* C 0 1 N N R 34.355 43.338 73.768 0.666 0.833 0.409 C1' LMS 27 1H5* H 0 0 N N N 35.748 45.568 70.283 -2.573 0.057 -1.153 H5'1 LMS 28 2H5* H 0 0 N N N 36.821 45.564 71.733 -3.568 1.384 -0.506 H5'2 LMS 29 H4* H 0 1 N N N 35.822 43.407 71.072 -1.883 1.671 1.347 H4' LMS 30 H3* H 0 1 N N N 33.323 44.519 70.812 -1.572 2.316 -1.483 H3' LMS 31 H2* H 0 1 N N N 32.929 44.970 73.212 0.495 1.224 -1.739 H2' LMS 32 H1* H 0 1 N N N 34.281 42.241 73.762 0.946 1.406 1.293 H1' LMS 33 1H6N H 0 0 N N N 33.817 42.870 80.515 5.114 -3.254 -0.871 H6N1 LMS 34 2H6N H 0 0 N N N 34.632 44.147 79.908 6.605 -2.606 -0.449 H6N2 LMS 35 1HN H 0 1 N N N 33.750 48.143 69.942 -3.288 -2.270 -1.124 HN1 LMS 36 2HN H 0 1 N N N 35.132 48.958 69.639 -4.890 -2.690 -1.406 HN2 LMS 37 sing N N 1 sing Y N 2 doub Y N 3 sing Y N 4 doub Y N 5 sing N N 6 sing Y N 7 doub Y N 8 sing Y N 9 sing Y N 10 sing Y N 11 doub Y N 12 sing N N 13 doub N N 14 doub N N 15 sing N N 16 sing N N 17 sing N N 18 sing N N 19 sing N N 20 sing N N 21 sing N N 22 sing N N 23 sing N N 24 sing N N 25 sing N N 26 sing N N 27 sing N N 28 sing N N 29 sing N N 30 sing N N 31 sing N N 32 sing N N 33 sing N N 34 sing N N 35 sing N N 36 sing N N 37 sing N N 38 sing N N 39 O=S(=O)(OCC3OC(n2cnc1c(ncnc12)N)C(O)C3O)N Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO[S](N)(=O)=O)[C@@H](O)[C@H]3O Nc1ncnc2n(cnc12)[CH]3O[CH](CO[S](N)(=O)=O)[CH](O)[CH]3O c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COS(=O)(=O)N)O)O)N c1nc(c2c(n1)n(cn2)C3C(C(C(O3)COS(=O)(=O)N)O)O)N InChI=1S/C10H14N6O6S/c11-8-5-9(14-2-13-8)16(3-15-5)10-7(18)6(17)4(22-10)1-21-23(12,19)20/h2-4,6-7,10,17-18H,1H2,(H2,11,13,14)(H2,12,19,20)/t4-,6-,7-,10-/m1/s1 GNZLUJQJDPRUTD-KQYNXXCUSA-N 5'-O-sulfamoyladenosine [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl sulfamate EBI RCSB RCSB